Literature DB >> 11345346

Vitreal macrophages express vascular endothelial growth factor in oxygen-induced retinopathy.

H L Naug1, J Browning, G A Gole, G Gobé.   

Abstract

PURPOSE: The possibility of vitreal macrophages playing an angiogenic role in oxygen-induced retinopathy (OIR) was investigated. Oxygen-induced retinopathy was produced in newborn animals with the purpose of modeling the proliferative phase of human retinopathy of prematurity (ROP).
MATERIALS AND METHODS: To produce OIR in neonatal mice, litters at postnatal day 7 were placed in 80-90% oxygen for a period of 5 days and then returned to room air. Pups were killed on days 7, 12, 15, 17 and 20 over the postnatal period and were perfusion-fixed using a saline wash-out, followed by 4% paraformaldehyde and then India Ink. Eyes were enucleated and either whole-mounted, or snap-frozen and cryosectioned. Immunostaining procedures were used to visualize macrophages and vascular endothelial growth factor (VEGF) protein. The primary antibodies used were anti-F4/80 and antimouse VEGF, respectively. Vitreal macrophages closely associated with the vitreo-retinal interface (within 25 microm of the inner limiting membrane) were counted. In situ hybridization procedures were used to analyse for the presence of VEGF mRNA transcript in vitreal macrophages.
RESULTS: Macrophage numbers were found to significantly increase (P < 0.05) in eyes from oxygen-treated animals compared with those from age-matched controls. A close spatial relationship was observed between macrophages and vitreal neovascular sprouts. In addition, vitreal macrophages were also found to transcribe and express VEGF in the oxygen-treated animals during the vasoproliferative phase.
CONCLUSIONS: Our results raise the possibility that vitreal macrophages play a role in the pathogenesis of OIR and by inference, ROP.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11345346     DOI: 10.1046/j.1442-9071.2000.00226.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  23 in total

1.  Monocytes/macrophages cooperate with progenitor cells during neovascularization and tissue repair: conversion of cell columns into fibrovascular bundles.

Authors:  Mirela Anghelina; Padma Krishnan; Leni Moldovan; Nicanor I Moldovan
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

2.  Host myeloid cells are necessary for creating bioengineered human vascular networks in vivo.

Authors:  Juan M Melero-Martin; Maria E De Obaldia; Patrick Allen; Andrew C Dudley; Michael Klagsbrun; Joyce Bischoff
Journal:  Tissue Eng Part A       Date:  2010-08       Impact factor: 3.845

3.  Effect of angiotensin II type 1 receptor blocker and angiotensin converting enzyme inhibitor on the intraocular growth factors and their receptors in streptozotocin-induced diabetic rats.

Authors:  Ik Soo Byon; Dong Hyun Lee; Eun Sook Jun; Min Kyu Shin; Sung Who Park; Ji Eun Lee
Journal:  Int J Ophthalmol       Date:  2017-06-18       Impact factor: 1.779

4.  Targeting myeloid cells in ischemic retinal vascular diseases.

Authors:  Christina Nürnberg; Norbert Kociok; Antonia M Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-08-21       Impact factor: 3.117

5.  Spatial distribution of CD115+ and CD11b+ cells and their temporal activation during oxygen-induced retinopathy in mice.

Authors:  Claudia Brockmann; Sabrina Dege; Sergio Crespo-Garcia; Norbert Kociok; Tobias Brockmann; Olaf Strauß; Antonia M Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-11-28       Impact factor: 3.117

Review 6.  Diverse roles of macrophages in intraocular neovascular diseases: a review.

Authors:  Ye-Di Zhou; Shigeo Yoshida; Ying-Qian Peng; Yoshiyuki Kobayashi; Lu-Si Zhang; Luo-Sheng Tang
Journal:  Int J Ophthalmol       Date:  2017-12-18       Impact factor: 1.779

7.  Visualizing HIF-1α mRNA in a Subpopulation of Bone Marrow-Derived Cells to Predict Retinal Neovascularization.

Authors:  Md Imam Uddin; Tyler C Kilburn; Craig L Duvall; John S Penn
Journal:  ACS Chem Biol       Date:  2020-10-20       Impact factor: 5.100

8.  Genetic and pharmacological inhibition of JNK ameliorates hypoxia-induced retinopathy through interference with VEGF expression.

Authors:  Monica Guma; Jordi Rius; Karen X Duong-Polk; Gabriel G Haddad; James D Lindsey; Michael Karin
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-11       Impact factor: 11.205

9.  Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity.

Authors:  Eun Jee Chung; Ji Hyun Kim; Hyun Seok Ahn; Hyoung Jun Koh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-08-10       Impact factor: 3.117

10.  Treatment of retinopathy of prematurity: a review of conventional and promising new therapeutic options.

Authors:  Fatih Mehmet Mutlu; Serdar Umit Sarici
Journal:  Int J Ophthalmol       Date:  2013-04-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.